Clinical trial

Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

NCT01433913

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-01

PhasePHASE2

Study timeline

Study start (unknown)2011-11-01Date precision: month

Registry last updated2018-01-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adenocarcinoma of the Prostateunresolved

Recurrent Prostate Cancerunresolved

Stage I Prostate Cancerunresolved

Stage IIA Prostate Cancerunresolved

Stage IIB Prostate Cancerunresolved

Interventions

metformin hydrochlorideDRUG · verified · RxNorm: metformin hydrochloride

laboratory biomarker analysisOTHER

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

TucsonArizona, United States2 Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01433913 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.